Evidence map›Paper›PMID 20966960›Full record

ArticleCell death and differentiation2011

Caspase-3-dependent export of TCTP: a novel pathway for antiapoptotic intercellular communication.

I Sirois, M-A Raymond, N Brassard, J-F Cailhier, M Fedjaev, K Hamelin, I Londono, M Bendayan, A V Pshezhetsky, M-J Hébert

Registry-linked trialAbstract read
In one paragraph

Article in Cell death and differentiation, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05490953 (Enhancing Effect on Tumour Apoptosis With the Combined Use of Pentoxifylline Plus Chemotherapeutical Agents in Pediatrics and AYA Patients With Hodgkin´s Lymphoma), which is not on this map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05490953 phase4unknown statusnot on this mapstarted 2022, after this paper: background citation

Enhancing Effect on Tumour Apoptosis With the Combined Use of Pentoxifylline Plus Chemotherapeutical Agents in Pediatrics and AYA Patients With Hodgkin´s Lymphoma

TypeinterventionalSponsorUniversity of GuadalajaraRan2022 to 2024Enrolled30ConditionsHodgkin LymphomaArmsPentoxifylline, Placebo
3 · Its place in the literature

Who cites it

42 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Review
  18. Review
  19. Article
  20. Apoptotic cell-derived exosomes: messages from dying cells.Experimental & molecular medicine · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

I SiroisResearch Centre, Centre hospitalier de l'Université de Montréal (CRCHUM), 1560 rue Sherbrooke Est, Montréal, Quebec, Canada.
M-A Raymond
N Brassard
J-F Cailhier
M Fedjaev
K Hamelin
I Londono
M Bendayan
A V Pshezhetsky
M-J Hébert

Funding

Canadian Institutes of Health Research MOP-15447Canadian Institutes of Health Research MOP-66980
6 · The paper itself

Abstract

The apoptotic program incorporates a paracrine component of importance in fostering tissue repair at sites of apoptotic cell deletion. As this paracrine pathway likely bears special importance in maladaptive intercellular communication leading to vascular remodeling, we aimed at further defining the mediators produced by apoptotic endothelial cells (EC), using comparative and functional proteomics. Apoptotic EC were found to release nanovesicles displaying ultrastructural characteristics, protein markers and functional activity that differed from apoptotic blebs. Tumor susceptibility gene 101 and translationally controlled tumor protein (TCTP) were identified in nanovesicle fractions purified from medium conditioned by apoptotic EC and absent from purified apoptotic blebs. Immunogold labeling identified TCTP on the surface of nanovesicles purified from medium conditioned by apoptotic EC and within multivesicular blebs in apoptotic EC. These nanovesicles induced an extracellular signal-regulated kinases 1/2 (ERK 1/2)-dependent antiapoptotic phenotype in vascular smooth muscle cells (VSMC), whereas apoptotic blebs did not display antiapoptotic activity on VSMC. Caspase-3 biochemical inhibition and caspase-3 RNA interference in EC submitted to a proapoptotic stimulus inhibited the release of nanovesicles. Also, TCTP siRNAs in EC attenuated the antiapoptotic activity of purified nanovesicles on VSMC. Collectively, these results identify TCTP-bearing nanovesicles as a novel component of the paracrine apoptotic program of potential importance in vascular repair.

Indexed as

ApoptosisCell CommunicationAnimalsBiomarkers, TumorCaspase 3Endothelial CellsEnzyme ActivationExosomesHumansNanostructuresProtein TransportRatsSerumTumor Protein, Translationally-Controlled 1Umbilical VeinsBiomarkers, TumorCaspase 3TPT1 protein, humanTpt1 protein, ratTumor Protein, Translationally-Controlled 1

Identifiers

PMID20966960
PMCPMC3131994

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.